Gain Therapeutics, Inc. (GANX) vs Fractyl Health, Inc. (GUTS)

Gain Therapeutics, Inc. and Fractyl Health, Inc. are both Biotechnology companies. Gain Therapeutics, Inc. and Fractyl Health, Inc. are of similar size ($80.3M and $76.4M). Gain Therapeutics, Inc. grew revenue faster over the last twelve months: 18.4% against −22.5%. Across the 12 metrics below, Gain Therapeutics, Inc. leads on 7 and Fractyl Health, Inc. on 5.

Valuation

Metric GANX GUTS Biotechnology median
P/E n/m n/m 7.88
P/S 397.40 835.89 11.47
P/B 6.87 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 332.17 656.39 10.73
Earnings yield (27.62%) (179.59%) (28.84%)
Free cash flow yield (24.45%) (106.75%) (23.03%)

Profitability

Metric GANX GUTS Biotechnology median
Gross margin 0.00% 46.24% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (268.30%) 1,063.04% (57.72%)
Return on assets (159.22%) (146.75%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GANX GUTS Biotechnology median
Revenue growth (TTM) 18.36% (22.50%) 5.64%
EPS growth (last fiscal year) 31.46% (14.81%) —
Revenue growth, 5-year CAGR 21.79% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GANX GUTS Biotechnology median
Debt to equity 0.03 (18.29) 0.00
Current ratio 4.36 3.15 4.73
Net debt to EBITDA 1.10 0.53 0.96

Dividend

Metric GANX GUTS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric GANX GUTS Biotechnology median
Market cap 80.30m 76.41m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack